Lucia Méndez Sánchez-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Prph2 knock-in mice recapitulate human central areolar choroidal dystrophy retinal degeneration and exhibit aberrant synaptic remodeling and microglial activation

    Cell Death and Disease, Vol. 14, Núm. 11

2022

  1. CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  2. Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration

    Cancers, Vol. 14, Núm. 16

2021

  1. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

    CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535

  2. Future approaches for treating chronic myeloid leukemia: Crispr therapy

    Biology, Vol. 10, Núm. 2, pp. 1-16

2020

  1. Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology

    Molecular Biology Reports, Vol. 47, Núm. 2, pp. 1381-1391

  2. Expression and functional analysis of the hydrogen peroxide biosensors HyPer and HyPer2 in C2C12 myoblasts/myotubes and single skeletal muscle fibres

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency

    PLoS ONE, Vol. 14, Núm. 5